Manganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primates.

[1]  L. Covolo,et al.  ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. , 2012, Neurotoxicology.

[2]  X. Fang,et al.  The Role of the Parkinson's Disease Gene PARK9 in Essential Cellular Pathways and the Manganese Homeostasis Network in Yeast , 2012, PloS one.

[3]  D. Krainc,et al.  Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity , 2012, The Journal of Neuroscience.

[4]  J. Redmond,et al.  Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report , 2012, Journal of Medical Case Reports.

[5]  V. Uversky,et al.  Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases. , 2011, Metallomics : integrated biometal science.

[6]  Zhuohua Zhang,et al.  Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein* , 2011, The Journal of Biological Chemistry.

[7]  K. Jellinger,et al.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts , 2011, Acta Neuropathologica.

[8]  E. Richfield,et al.  Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice , 2011, Neuroscience.

[9]  T. Guilarte,et al.  Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. , 2011, Neurotoxicology.

[10]  H. Johansen-Berg,et al.  White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome. , 2010, Brain : a journal of neurology.

[11]  T. Cai,et al.  Manganese induces the overexpression of α-synuclein in PC12 cells via ERK activation , 2010, Brain Research.

[12]  D. Meier,et al.  In Vivo Measurement of Brain GABA Concentrations by Magnetic Resonance Spectroscopy in Smelters Occupationally Exposed to Manganese , 2010, Environmental health perspectives.

[13]  Tomás R. Guilarte,et al.  Manganese and Parkinson’s Disease: A Critical Review and New Findings , 2010, Environmental health perspectives.

[14]  L. Thurfjell,et al.  Clinical, neuroimaging and neurophysiological features in addicts with manganese‐ephedrone exposure , 2010, Acta neurologica Scandinavica.

[15]  T. Cai,et al.  α-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells , 2010, Brain Research Bulletin.

[16]  G. Wenning,et al.  Multiple system atrophy: an update , 2009, The Lancet Neurology.

[17]  T. Guilarte,et al.  Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  C. Colosimo,et al.  Parkinsonism due to ephedrone neurotoxicity: a case report , 2009, European journal of neurology.

[19]  D. Pearce,et al.  Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. , 2009, Biochemical and biophysical research communications.

[20]  T. Guilarte,et al.  Effects of chronic manganese exposure on working memory in non-human primates , 2009, Brain Research.

[21]  S. Lindquist,et al.  α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity , 2009, Nature Genetics.

[22]  L. Pham,et al.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism , 2008, Journal of neurochemistry.

[23]  A. Lees,et al.  Parkinsonism and dystonia caused by the illicit use of ephedrone—A longitudinal study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[24]  K. Becker,et al.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese‐exposed non‐human primates , 2008, Journal of neurochemistry.

[25]  Mari Yoshida,et al.  Multiple system atrophy: α‐synuclein and neuronal degeneration , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[26]  D. Perl,et al.  The Neuropathology of Manganese-Induced Parkinsonism , 2007, Journal of neuropathology and experimental neurology.

[27]  S. Fahn,et al.  Manganic encephalopathy due to “ephedrone” abuse , 2007, Movement disorders : official journal of the Movement Disorder Society.

[28]  Antonio P Strafella,et al.  Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. , 2007, Archives of neurology.

[29]  Hasan Meral,et al.  Parkinsonism Caused by Chronic Usage of Intravenous Potassium Permanganate , 2007, The neurologist.

[30]  J. Kordower,et al.  Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? , 2007, Neurobiology of Disease.

[31]  T. Guilarte,et al.  Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  T. Guilarte,et al.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.

[33]  T. Guilarte,et al.  Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates , 2006, Brain Research.

[34]  R. Bowler,et al.  Dose–effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders , 2006, Occupational and Environmental Medicine.

[35]  N. Kumar,et al.  Neuropsychological profiles of manganese neurotoxicity , 2006, European journal of neurology.

[36]  Hitoshi Takahashi,et al.  Cellular pathology in multiple system atrophy , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[37]  Sanae Nakagawa,et al.  Manganese exposure: neuropsychological and neurological symptoms and effects in welders. , 2006, Neurotoxicology.

[38]  N. Vanacore.  Epidemiological evidence on multiple system atrophy , 2005, Journal of Neural Transmission.

[39]  F. Campos,et al.  Effects of Manganese on Extracellular Levels of Dopamine in Rat Striatum: An Analysis In vivo by Brain Microdialysis , 2005, Neurochemical Research.

[40]  K. Jellinger,et al.  The role of α-synuclein in the pathogenesis of multiple system atrophy , 2005, Acta Neuropathologica.

[41]  Zhongqi Cheng,et al.  Water Manganese Exposure and Children’s Intellectual Function in Araihazar, Bangladesh , 2004, Environmental health perspectives.

[42]  O. Hornykiewicz,et al.  α-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter , 2004, Neuroscience Letters.

[43]  V. Uversky,et al.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.

[44]  J. Texcalac-Sangrador,et al.  Exposure to manganese: health effects on the general population, a pilot study in central Mexico. , 2001, Environmental research.

[45]  J. Clark,et al.  N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.

[46]  D Mergler,et al.  Early manifestations of manganese neurotoxicity in humans: an update. , 1997, Environmental research.

[47]  F. Parvez,et al.  Manganese exposure from drinking water and children's academic achievement. , 2012, Neurotoxicology.

[48]  L. Covolo,et al.  1 ATP 13 A 2 ( PARK 9 ) polymorphisms influence the neurotoxic effects of manganese , 2012 .

[49]  Altan Eşsizoğlu,et al.  [Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report]. , 2009, Turk psikiyatri dergisi = Turkish journal of psychiatry.

[50]  S. M. de la Monte,et al.  Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. , 2009, Journal of Alzheimer's disease : JAD.

[51]  N. Kumar.  A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese , 2009 .

[52]  Christopher Hartney,et al.  Neuropsychological sequelae of exposure to welding fumes in a group of occupationally exposed men. , 2003, International journal of hygiene and environmental health.

[53]  F. Träber,et al.  In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration , 2002, Amino Acids.

[54]  J A Frank,et al.  Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.